SARS-CoV-2 spike RBD in complex with neutralizing antibody UT28K

Tatsuhiko Ozawa (寄稿者)
Hideki Tani (寄稿者)
Yuki Anraku (寄稿者)
Shunsuke Kita (寄稿者)
Emiko Igarashi (寄稿者)
Yumiko Saga (寄稿者)
Noriko Inasaki (寄稿者)
Hitoshi Kawasuji (寄稿者)
Hiroshi Yamada (寄稿者)
Soichiro Sasaki (寄稿者)
Mayu Somekawa (寄稿者)
Jiei Sasaki (寄稿者)
Yoshihiro Hayakawa (寄稿者)
Yoshihiro Yamamoto (寄稿者)
Yoshitomo Morinaga (寄稿者)
Nobuyuki Kurosawa (寄稿者)
Masaharu Isobe (寄稿者)
Hideo Fukuhara (寄稿者)
Katsumi Maenaka (寄稿者)
Takao Hashiguchi (寄稿者)
Hiroyuki Kishi (寄稿者)
Isao Kitajima (寄稿者)
Shigeru Saito (寄稿者)
Hideki Niimi (寄稿者)

データセット

利用可能になった日	2022/05/25
出版社	Protein Data Bank (PDB)

DOI
10.2210/pdb7X7O/pdb

データセットにアクセス

https://www.wwpdb.org/pdb?id=pdb_00007x7o

1 学術論文

Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants
Ozawa, T., Tani, H., Anraku, Y., Kita, S., Igarashi, E., Saga, Y., Inasaki, N., Kawasuji, H., Yamada, H., Sasaki, S.-I., Somekawa, M., Sasaki, J., Hayakawa, Y., Yamamoto, Y., Morinaga, Y., Kurosawa, N., Isobe, M., Fukuhara, H., Maenaka, K. & Hashiguchi, T. & 4 others, Kishi, H., Kitajima, I., Saito, S. & Niimi, H., 2022/05/12, In: mAbs. 14, 1, p. 2072455
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

引用スタイル

Ozawa, T. (寄稿者), Tani, H. (寄稿者), Anraku, Y. (寄稿者), Kita, S. (寄稿者), Igarashi, E. (寄稿者), Saga, Y. (寄稿者), Inasaki, N. (寄稿者), Kawasuji, H. (寄稿者), Yamada, H. (寄稿者), Sasaki, S. (寄稿者), Somekawa, M. (寄稿者), Sasaki, J. (寄稿者), Hayakawa, Y. (寄稿者), Yamamoto, Y. (寄稿者), Morinaga, Y. (寄稿者), Kurosawa, N. (寄稿者), Isobe, M. (寄稿者), Fukuhara, H. (寄稿者), Maenaka, K. (寄稿者), Hashiguchi, T. (寄稿者), Kishi, H. (寄稿者), Kitajima, I. (寄稿者), Saito, S. (寄稿者), Niimi, H. (寄稿者) (2022/05/25). SARS-CoV-2 spike RBD in complex with neutralizing antibody UT28K. Protein Data Bank (PDB). 10.2210/pdb7X7O/pdb

SARS-CoV-2 spike RBD in complex with neutralizing antibody UT28K

DOI

データセットにアクセス

研究成果

Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants

引用スタイル